Literature DB >> 2928465

Hypertrophy of cultured bovine aortic endothelium following irradiation.

E M Rosen1, D W Vinter, I D Goldberg.   

Abstract

The vascular endothelium is a vital multifunctional tissue which covers the entire luminal surface of the circulatory system. Loss of continuity of the endothelial lining normally results in cell migration and proliferation to make up for cell loss and to ensure that exposure of the thrombogenic subendothelium to platelets and clotting factors is minimized. We showed that ionizing radiation (400-3000 cGy) causes dose-dependent cell loss from confluent monolayer cultures of bovine aortic endothelium, which cannot immediately be compensated by cell proliferation. Within 24 h, the remaining attached cells undergo substantial somatic hypertrophy (evidenced by increased protein content, cell volume, and attachment area) but remain diploid. If cell loss is not excessive, monolayer continuity is restored within several days. Although reduced protein degradation may contribute, most of the protein accumulation is due to synthesis of new protein. Unlike endothelium, irradiation of smooth muscle cultures causes neither cell loss nor increased protein synthesis. Hypertrophy of irradiated endothelial cells appears to be a consequence of a proliferative stimulus (cell loss) in a population of cells which is unable to divide. It can be modulated by replating irradiated cells at different densities. We suggest that endothelial hypertrophy is an early vascular homeostatic response before clonal proliferation of surviving cells or repopulation by cells from outside of the irradiated field can compensate for cell loss.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2928465

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  9 in total

1.  Pelvic irradiation modulates the pharmacokinetics of cisplatin in the plasma and lymphatic system.

Authors:  Tung-Hu Tsai; Yu-Jen Chen; Mei-Ling Hou; Li-Ying Wang; Hung-Chi Tai; Chen-Hsi Hsieh
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

Review 2.  [Intravascular irradiation in the combined therapy and prevention of restenosis. Overview].

Authors:  D Baumgart; U Quast; R Erbel
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

3.  The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.

Authors:  J F Reindel; R A Roth
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

4.  Therapeutic efficacy of 188Re-liposome in a C26 murine colon carcinoma solid tumor model.

Authors:  Ya-Jen Chang; Chin-Wei Hsu; Chih-Hsien Chang; Keng-Li Lan; Gann Ting; Te-Wei Lee
Journal:  Invest New Drugs       Date:  2012-12-09       Impact factor: 3.850

5.  Lymphatic metastasis from tumors transplanted into the pre-irradiated footpad of the rat.

Authors:  H J van der Planken; A F Hermens
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

6.  Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update.

Authors:  D Liermann; J Kirchner; R Bauernsachs; B Schopohl; H D Böttcher
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

7.  Local pelvic irradiation modulates Pharmacokinetics of 5-Fluorouracil in the plasma but not in the Lymphatic System.

Authors:  Chen-Hsi Hsieh; Mei-Ling Hou; Li-Ying Wang; Hung-Chi Tai; Tung-Hu Tsai; Yu-Jen Chen
Journal:  BMC Cancer       Date:  2015-04-26       Impact factor: 4.430

8.  Low dose cranial irradiation-induced cerebrovascular damage is reversible in mice.

Authors:  Nikolett Sándor; Fruzsina R Walter; Alexandra Bocsik; Petra Sántha; Boglárka Schilling-Tóth; Violetta Léner; Zoltán Varga; Zsuzsanna Kahán; Mária A Deli; Géza Sáfrány; Hargita Hegyesi
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 9.  Local Radiotherapy Affects Drug Pharmacokinetics-Exploration of a Neglected but Significant Uncertainty of Cancer Therapy.

Authors:  Yu-Jen Chen; Tung-Hu Tsai; Li-Ying Wang; Chen-Hsi Hsieh
Journal:  Technol Cancer Res Treat       Date:  2017-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.